Physician Assistant Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Ann Coots

Physician Assistant, Surgical San Mateo, CA Physician Assistant

NPI 1831363977 CMS profile 10725855

280 Baldwin Ave, San Mateo, CA 94401

Open in the dashboard

General payments

$5,224

209 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ann Coots of San Mateo, CA is reported in the CMS Open Payments database as having received $5,224 across 209 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,054 73
2024 General $1,644 60
2023 General $1,057 58
2022 General $469 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ann Coots
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Ann Coots were reported at $2,054. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Ann Coots Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $0 $111 $36–$285 $132
2022 $469 $126 $44–$350 $149
2023 $1,057 $137 $47–$355 $160
2024 $1,644 $146 $49–$384 $164
2025 $2,054 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. AbbVie, Inc. $776 30 payments
  2. Genzyme Corporation $674 23 payments
  3. Incyte Corporation $544 17 payments
  4. Regeneron Healthcare Solutions, Inc. $540 21 payments
  5. Galderma Laboratories, L.P. $418 12 payments
  6. Sun Pharmaceutical Industries Inc. $404 20 payments
  7. UCB, Inc. $320 12 payments
  8. Lilly USA, LLC $313 15 payments
  9. LEO Pharma Inc. $272 21 payments
  10. E.R. Squibb & Sons, L.L.C. $191 6 payments
  11. Other $774 32 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $5,224 209 payments
Products named General payments · program years 2022–2025
  1. DUPIXENT Immunology $749 25 payments
  2. OPZELURA $544 17 payments
  3. SKYRIZI $347 14 payments
  4. RINVOQ $335 12 payments
  5. NEMLUVIO $324 8 payments
  6. TALTZ $313 15 payments
  7. Bimzelx $300 11 payments
  8. DUPIXENT Inflammation And Immunology $288 12 payments
  9. ADBRY $272 21 payments
  10. EBGLYSS $260 13 payments
  11. Other $2,270 102 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

209 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record